Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)Ivan Gentile, Nicola Coppola, Margherita Macera et al.|Hepatology International|2018Cited by 63
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infectionIvan Gentile, Federica Portunato, Antonio Riccardo Buonomo et al.|Journal of Nephrology|2019Cited by 30
Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemicErica Pietroluongo, Mario Giuliano, Pietro De Placido et al.|Mediastinum|2022Cited by 10
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrenceAntonio Riccardo Buonomo, Ivan Gentile, Riccardo Scotto et al.|Medicine|2020Cited by 9
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort.Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo et al.|PubMed|2019Cited by 6